Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Vascular Surgery

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    March 2019
  1. ANDERSON RH
    Hypoplastic left heart syndrome: the importance of phenotypic diagnosis.
    Heart. 2019;105:499.
    PubMed     Text format    


    December 2018
  2. FEINBERG J, Nielsen EE, Gluud C, Jakobsen JC, et al
    Cochrane Corner: drug-eluting stents versus bare-metal stents for acute coronary syndrome.
    Heart. 2018;104:1895-1897.
    PubMed     Text format    


  3. CAPODANNO D
    Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update.
    Heart. 2018;104:1976-1983.
    PubMed     Text format    


    November 2018
  4. HUANG HD, Lombardi WL, Steinberg ZL
    Young man presenting with out-of-hospital cardiac arrest.
    Heart. 2018;104:1771-1802.
    PubMed     Text format     Abstract available


  5. HEUTS S, Adriaans BP, Gerretsen S, Natour E, et al
    Aortic elongation part II: the risk of acute type A aortic dissection.
    Heart. 2018;104:1778-1782.
    PubMed     Text format     Abstract available


    October 2018
  6. TESTORI C, Beitzke D, Mangold A, Sterz F, et al
    Out-of-hospital initiation of hypothermia in ST-segment elevation myocardial infarction: a randomised trial.
    Heart. 2018 Oct 25. pii: heartjnl-2018-313705. doi: 10.1136/heartjnl-2018-313705
    PubMed     Text format     Abstract available


  7. OTTO CM
    Heartbeat: improving outcomes after myocardial infarction.
    Heart. 2018;104:1553-1554.
    PubMed     Text format    


    September 2018
  8. AL-LAMEE RK, Nowbar AN, Francis DP
    Percutaneous coronary intervention for stable coronary artery disease.
    Heart. 2018 Sep 21. pii: heartjnl-2017-312755. doi: 10.1136/heartjnl-2017-312755
    PubMed     Text format     Abstract available


  9. OTTO CM
    Heartbeat: The ongoing controversy of intervention for chronic total coronary occlusions.
    Heart. 2018;104:1385-1387.
    PubMed     Text format    


  10. SCHWARTZ I, McCracken CE, Petit CJ, Sachdeva R, et al
    Late outcomes after the Fontan procedure in patients with single ventricle: a meta-analysis.
    Heart. 2018;104:1508-1514.
    PubMed     Text format     Abstract available


  11. GALAPPATTHY P, Bataduwaarachchi VR, Ranasinghe P, Galappatthy GKS, et al
    Management, characteristics and outcomes of patients with acute coronary syndrome in Sri Lanka.
    Heart. 2018;104:1424-1431.
    PubMed     Text format     Abstract available


    June 2018
  12. FAHEY JK, Ihdayhid AR, White AJ
    A 42-year-old woman with acute myocardial infarction.
    Heart. 2018 Jun 28. pii: heartjnl-2017-312779. doi: 10.1136/heartjnl-2017-312779
    PubMed     Text format    


  13. OTTO CM
    Heartbeat: socioeconomic deprivation is associated with non-cardiovascular mortality in chronic heart failure patients.
    Heart. 2018;104:961-963.
    PubMed     Text format    


    May 2018
  14. KANDAN SR, Johnson TW
    Management of percutaneous coronary intervention complications.
    Heart. 2018 May 14. pii: heartjnl-2017-311155. doi: 10.1136/heartjnl-2017-311155
    PubMed     Text format    


  15. VANEZIS AP, Arnold JR, Rodrigo G, Lai FY, et al
    Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial.
    Heart. 2018 May 10. pii: heartjnl-2018-313091. doi: 10.1136/heartjnl-2018-313091
    PubMed     Text format     Abstract available


    April 2018
  16. NIJJER SS
    Clinical outcomes of potent antiplatelets compared with clopidogrel in ST elevation myocardial infarction.
    Heart. 2018 Apr 17. pii: heartjnl-2018-312967. doi: 10.1136/heartjnl-2018-312967
    PubMed     Text format    


  17. JENKINS D
    New interventions to treat chronic thromboembolic pulmonary hypertension.
    Heart. 2018 Apr 10. pii: heartjnl-2017-312110. doi: 10.1136/heartjnl-2017-312110
    PubMed     Text format     Abstract available


  18. AVITABILE CM, Goldberg DJ, Leonard MB, Wei ZA, et al
    Leg lean mass correlates with exercise systemic output in young Fontan patients.
    Heart. 2018;104:680-684.
    PubMed     Text format     Abstract available


    March 2018
  19. JOHNSTONE SR, Isakson BE
    'Gaps' in targeted ischaemic injury therapies in ST-elevation myocardial infarction.
    Heart. 2018 Mar 30. pii: heartjnl-2018-313084. doi: 10.1136/heartjnl-2018-313084
    PubMed     Text format    


  20. ENGSTROM T, Nepper-Christensen L, Helqvist S, Klovgaard L, et al
    Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.
    Heart. 2018 Mar 30. pii: heartjnl-2017-312774. doi: 10.1136/heartjnl-2017-312774
    PubMed     Text format     Abstract available


  21. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.
    PubMed     Text format    


  22. CAULDWELL M, Steer PJ, Bonner S, Asghar O, et al
    Retrospective UK multicentre study of the pregnancy outcomes of women with a Fontan repair.
    Heart. 2018;104:401-406.
    PubMed     Text format     Abstract available


  23. DE BELDER AJ
    Rotational atherectomy: re-emergence of an old technique.
    Heart. 2018;104:440-448.
    PubMed     Text format    


  24. STOJKOVIC S, Milasinovic D
    Chronic total occlusion percutaneous coronary intervention in clinical practice: novel grounds to be EXPLOREd.
    Heart. 2018 Mar 1. pii: heartjnl-2018-312940. doi: 10.1136/heartjnl-2018-312940.
    PubMed     Text format    


    February 2018
  25. GARCIA-ARRIBAS D, Vilacosta I, Ortega Candil A, Rodriguez Rey C, et al
    Usefulness of positron emission tomography/computed tomography in patients with valve-tube graft infection.
    Heart. 2018 Feb 22. pii: heartjnl-2017-312918. doi: 10.1136/heartjnl-2017-312918
    PubMed     Text format     Abstract available


  26. ELIAS J, van Dongen IM, Ramunddal T, Laanmets P, et al
    Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.
    Heart. 2018 Feb 20. pii: heartjnl-2017-312698. doi: 10.1136/heartjnl-2017-312698
    PubMed     Text format     Abstract available


  27. BRAVO CA, Hirji SA, Bhatt DL, Gluud C, et al
    Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease.
    Heart. 2018 Feb 8. pii: heartjnl-2017-312857. doi: 10.1136/heartjnl-2017-312857.
    PubMed     Text format    


  28. FOO CY, Bonsu KO, Nallamothu BK, Reid CM, et al
    Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis.
    Heart. 2018 Feb 5. pii: heartjnl-2017-312517. doi: 10.1136/heartjnl-2017-312517.
    PubMed     Text format     Abstract available


  29. GAASCH WH, Meyer TE
    Secondary mitral regurgitation (part 2): deliberations on mitral surgery and transcatheter repair.
    Heart. 2018 Feb 2. pii: heartjnl-2017-312002. doi: 10.1136/heartjnl-2017-312002.
    PubMed     Text format     Abstract available


  30. OLIER I, Sirker A, Hildick-Smith DJR, Kinnaird T, et al
    Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention.
    Heart. 2018 Feb 2. pii: heartjnl-2017-312366. doi: 10.1136/heartjnl-2017-312366.
    PubMed     Text format     Abstract available


  31. HAYS BS, Baker M, Laib A, Tan W, et al
    Histopathological abnormalities in the central arteries and veins of Fontan subjects.
    Heart. 2018;104:324-331.
    PubMed     Text format     Abstract available


  32. AVERIN K, Byrnes JW, Benscoter DT, Whiteside W, et al
    Life-threatening airway bleeding after palliation of single ventricle congenital heart disease.
    Heart. 2018;104:254-260.
    PubMed     Text format     Abstract available


  33. LATUS H, Nassar MS, Wong J, Hachmann P, et al
    Ventricular function and vascular dimensions after Norwood and hybrid palliation of hypoplastic left heart syndrome.
    Heart. 2018;104:244-252.
    PubMed     Text format     Abstract available


    January 2018
  34. AKOUM N
    Persistently high incidence of postcoronary bypass atrial fibrillation: possible mechanisms.
    Heart. 2018 Jan 19. pii: heartjnl-2017-312627. doi: 10.1136/heartjnl-2017-312627
    PubMed     Text format    


  35. FILARDO G, Damiano RJ Jr, Ailawadi G, Thourani VH, et al
    Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312150. doi: 10.1136/heartjnl-2017-312150
    PubMed     Text format     Abstract available


  36. SMILOWITZ NR, Gupta N, Guo Y, Beckman JA, et al
    Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery.
    Heart. 2018 Jan 5. pii: heartjnl-2017-312391. doi: 10.1136/heartjnl-2017-312391.
    PubMed     Text format     Abstract available


  37. ARRI SS, Patterson T, Williams RP, Moschonas K, et al
    Myocardial revascularisation in high-risk subjects.
    Heart. 2018;104:166-179.
    PubMed     Text format    


  38. MAZNYCZKA AM, McCartney P, Berry C
    Reference invasive tests of microvascular injury in myocardial infarction.
    Heart. 2018;104:90-92.
    PubMed     Text format    


  39. DE WAARD GA, Fahrni G, de Wit D, Kitabata H, et al
    Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction.
    Heart. 2018;104:127-134.
    PubMed     Text format     Abstract available


    December 2017
  40. QUANDT D, Ramchandani B, Penford G, Stickley J, et al
    Right ventricular outflow tract stent versus BT shunt palliation in Tetralogy of Fallot.
    Heart. 2017;103:1985-1991.
    PubMed     Text format     Abstract available


  41. GNANENTHIRAN SR, Kritharides L, D'Souza M, Lowe HC, et al
    Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.
    Heart. 2017;103:1962-1969.
    PubMed     Text format     Abstract available


  42. DE CARLO M, Liga R
    Elderly patients with non-ST-elevation acute coronary syndromes: a call for action.
    Heart. 2017;103:1932-1933.
    PubMed     Text format    


    November 2017
  43. TOYOTA T, Morimoto T, Shiomi H, Yamaji K, et al
    Single-session versus staged procedures for elective multivessel percutaneous coronary intervention.
    Heart. 2017 Nov 16. pii: heartjnl-2017-312117. doi: 10.1136/heartjnl-2017-312117
    PubMed     Text format     Abstract available


  44. GRAY AM, Murphy J, Altman DG, Benedetto U, et al
    One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.
    Heart. 2017;103:1719-1726.
    PubMed     Text format     Abstract available


  45. TANG E, Wei ZA, Whitehead KK, Khiabani RH, et al
    Effect of Fontan geometry on exercise haemodynamics and its potential implications.
    Heart. 2017;103:1806-1812.
    PubMed     Text format     Abstract available


  46. EGBE AC, Khan AR, Ammash NM, Barbara DW, et al
    Predictors of procedural complications in adult Fontan patients undergoing non-cardiac procedures.
    Heart. 2017;103:1813-1820.
    PubMed     Text format     Abstract available


  47. SILVAIN J, Nguyen LS, Spagnoli V, Kerneis M, et al
    Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311975. doi: 10.1136/heartjnl-2017-311975.
    PubMed     Text format     Abstract available


  48. SINDET-PEDERSEN C, Staerk L, Lamberts M, Gerds TA, et al
    Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311976. doi: 10.1136/heartjnl-2017-311976.
    PubMed     Text format     Abstract available


    October 2017
  49. DE MARIA GL, Patel N, Banning AP
    Obstructive left main stem coronary disease: is it time to recommend coronary stenting?
    Heart. 2017 Oct 23. pii: heartjnl-2016-310880. doi: 10.1136/heartjnl-2016-310880
    PubMed     Text format    


  50. WANG N, Fulcher J, Abeysuriya N, Adams M, et al
    Predictors of successful chronic total occlusion percutaneous coronary interventions: a systematic review and meta-analysis.
    Heart. 2017 Oct 6. pii: heartjnl-2017-311986. doi: 10.1136/heartjnl-2017-311986.
    PubMed     Text format     Abstract available


  51. OHUCHI H, Negishi J, Hayama Y, Miyazaki A, et al
    Renal resistive index reflects Fontan pathophysiology and predicts mortality.
    Heart. 2017;103:1631-1637.
    PubMed     Text format     Abstract available


    September 2017
  52. PICCOLO R, Franzone A, Windecker S
    From bare metal to barely anything: an update on coronary stenting.
    Heart. 2017 Sep 19. pii: heartjnl-2016-310877. doi: 10.1136/heartjnl-2016-310877
    PubMed     Text format    


  53. BUTTAR SN, Yan TD, Taggart DP, Tian DH, et al
    Long-term and short-term outcomes of using bilateral internal mammary artery grafting versus left internal mammary artery grafting: a meta-analysis.
    Heart. 2017;103:1419-1426.
    PubMed     Text format     Abstract available


  54. NAIROOZ R, Saad M, Elgendy IY, Mahmoud AN, et al
    Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: a meta-analysis of randomised trials.
    Heart. 2017;103:1427-1434.
    PubMed     Text format     Abstract available


    August 2017
  55. ALFREDSSON J, Neely B, Neely ML, Bhatt DL, et al
    Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
    Heart. 2017;103:1168-1176.
    PubMed     Text format     Abstract available


    July 2017
  56. KURLANSKY PA
    Arterial grafting for coronary revascularisation and the illusive search for truth.
    Heart. 2017 Jul 12. pii: heartjnl-2017-311289. doi: 10.1136/heartjnl-2017-311289
    PubMed     Text format    


  57. UDINK TEN CATE FEA, Trieschmann U, Germund I, Hannes T, et al
    Stenting the Fontan pathway in paediatric patients with obstructed extracardiac conduits.
    Heart. 2017;103:1111-1116.
    PubMed     Text format     Abstract available


  58. NAIROOZ R, Saad M, Sardar P, Aronow WS, et al
    Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
    Heart. 2017;103:1096-1103.
    PubMed     Text format     Abstract available


  59. BRUGALETTA S, Sabate M
    A longer look at trial evidence of bioresorbable vascular scaffolds.
    Heart. 2017;103:1061-1062.
    PubMed     Text format    


    June 2017
  60. COCKBURN J, Hildick-Smith DJ, Trivedi U, de Belder AJ, et al
    Re: A case for palliative percutaneous coronary intervention.
    Heart. 2017;103:967.
    PubMed     Text format    


  61. BLAKE SR
    A case for palliative percutaneous coronary intervention.
    Heart. 2017;103:967.
    PubMed     Text format    


    April 2017
  62. WILSON SJ, Newby DE, Dawson D, Irving J, et al
    Duration of dual antiplatelet therapy in acute coronary syndrome.
    Heart. 2017;103:573-580.
    PubMed     Text format     Abstract available


  63. NADIR MA
    Inverse prognostic value of post-percutaneous coronary intervention fractional flow reserve in patients with non-ST segment elevation myocardial infarction.
    Heart. 2017;103:564.
    PubMed     Text format    


    March 2017
  64. OPOTOWSKY AR, Baraona FR, Mc Causland FR, Loukas B, et al
    Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
    Heart. 2017;103:434-442.
    PubMed     Text format     Abstract available


  65. CAVALCANTE R, Sotomi Y, Zeng Y, Lee CW, et al
    Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Heart. 2017;103:428-433.
    PubMed     Text format     Abstract available


  66. MOSS AJ, Dweck MR, Flapan AD
    A 33-year-old man with atypical chest pain.
    Heart. 2017;103:474.
    PubMed     Text format     Abstract available


  67. HARBRON RW, Chapple CL, O'Sullivan JJ, Best KE, et al
    Survival adjusted cancer risks attributable to radiation exposure from cardiac catheterisations in children.
    Heart. 2017;103:341-346.
    PubMed     Text format     Abstract available


    February 2017
  68. KIM YY, Rathod RH, Gauvreau K, Keenan EM, et al
    Factors associated with severe aortic dilation in patients with Fontan palliation.
    Heart. 2017;103:280-286.
    PubMed     Text format     Abstract available


  69. LEDWOCH J, Fuernau G, Desch S, Eitel I, et al
    Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock.
    Heart. 2017 Feb 7. pii: heartjnl-2016-310403. doi: 10.1136/heartjnl-2016-310403.
    PubMed     Text format     Abstract available


    January 2017
  70. ALSAIED T, Bokma JP, Engel ME, Kuijpers JM, et al
    Factors associated with long-term mortality after Fontan procedures: a systematic review.
    Heart. 2017;103:104-110.
    PubMed     Text format     Abstract available


  71. DANZI GB, Piccolo R, Chevalier B, Urban P, et al
    Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.
    Heart. 2017;103:111-116.
    PubMed     Text format     Abstract available


  72. VARCOE RW, Clayton TC, Gray HH, de Belder MA, et al
    Impact of call-to-balloon time on 30-day mortality in contemporary practice.
    Heart. 2017;103:117-124.
    PubMed     Text format     Abstract available


  73. CASSESE S, Xhepa E, Kastrati A
    Biodegradable-polymer drug-eluting stents: back to the future?
    Heart. 2017;103:91-92.
    PubMed     Text format    


    December 2016
  74. KIM NH, D'Armini AM, Grimminger F, Grunig E, et al
    Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
    Heart. 2016 Dec 23. pii: heartjnl-2016-309621. doi: 10.1136/heartjnl-2016-309621
    PubMed     Text format     Abstract available


  75. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P, Reiter RJ
    Melatonin for cardioprotection in ST elevation myocardial infarction: are we ready for the challenge?
    Heart. 2016 Dec 7. pii: heartjnl-2016-310689. doi: 10.1136/heartjnl-2016-310689.
    PubMed     Text format    


    November 2016
  76. EISEN A, Bhatt DL
    Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting.
    Heart. 2016 Nov 25. pii: heartjnl-2015-309022. doi: 10.1136/heartjnl-2015-309022
    PubMed     Text format    


    September 2016
  77. JONES DA, Khambata RS, Andiapen M, Rathod KS, et al
    Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention.
    Heart. 2016 Sep 28. pii: heartjnl-2016-309748. doi: 10.1136/heartjnl-2016-309748
    PubMed     Text format     Abstract available


    August 2016
  78. SHAH R, Mooney MA
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335.
    PubMed     Text format    


  79. NAVARESE E, Kowalewski M
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335-6.
    PubMed     Text format    


  80. MCWILLIAMS E, Zehr K, Alshehri A
    An unusual shadow above the aortic valve.
    Heart. 2016 Aug 11. pii: heartjnl-2016-309932. doi: 10.1136/heartjnl-2016-309932
    PubMed     Text format     Abstract available


  81. MANGION K, Carrick D, Hennigan BW, Payne AR, et al
    Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.
    Heart. 2016 Aug 8. pii: heartjnl-2015-308660. doi: 10.1136/heartjnl-2015-308660.
    PubMed     Text format     Abstract available


    July 2016
  82. DI TANO G, Caretta G, De Maria R, Parolini M, et al
    Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Heart. 2016 Jul 27. pii: heartjnl-2016-309673. doi: 10.1136/heartjnl-2016-309673
    PubMed     Text format     Abstract available


  83. PETRONI T, Zaman A, Georges JL, Hammoudi N, et al
    Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians.
    Heart. 2016 Jul 13. pii: heartjnl-2015-308905. doi: 10.1136/heartjnl-2015-308905
    PubMed     Text format     Abstract available


    June 2016
  84. SIZAROV A, Raimondi F, Bonnet D, Boudjemline Y, et al
    Vascular anatomy in children with pulmonary hypertension regarding the transcatheter Potts shunt.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309352. doi: 10.1136/heartjnl-2016-309352
    PubMed     Text format     Abstract available


    May 2016
  85. FUKUI S, Ogo T, Takaki H, Ueda J, et al
    Efficacy of cardiac rehabilitation after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Heart. 2016 May 24. pii: heartjnl-2015-309230. doi: 10.1136/heartjnl-2015-309230
    PubMed     Text format     Abstract available


    March 2016
  86. SHI WY, Yong MS, McGiffin DC, Jain P, et al
    Heart transplantation in Fontan patients across Australia and New Zealand.
    Heart. 2016 Mar 21. pii: heartjnl-2015-308848. doi: 10.1136/heartjnl-2015-308848
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: